CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Mobile Medical Corporation

Mobile Medical Corporation is a Bethel Park, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hayes Management Consulting

As a trusted advisor to healthcare organizations, Hayes leverages its decades of experience and real world expertise to help clients succeed in a disruptive and evolving healthcare market. From streamlining operations to optimizing systems to developing organizational strategy, Hayes consultants deliver customized services that leave each client fully prepared for success.

Luma Health

Needing healthcare can be hard — getting care shouldnt be. We built Luma Health because we are all patients. We believe it should be easy to see and connect with our doctor. To get the care we need, when we need it. Ours is a new vision aligned around letting systems deliver high-quality healthcare, lower the burden on staff, and provide the modern, mobile-first experience we all deserve.

Specialty Media Inc

Specialty Media provides innovative products and services of the highest quality to the academic and industrial biological research community. Our products and services are designed with the needs of the bench researcher in mind. Specialty Media offers

Sanara MedTech

With our focus on improving patient outcomes with evidence-based healing solutions, we develop, market and distribute biotechnology products to physicians, hospitals, clinics and all post-acute care settings. We are constantly seeking long-term partnerships with a focus on products that produce efficacious outcomes at a lower overall cost. Our products are primarily sold in the North American surgical tissue repair and advanced wound care markets.